[95] PQQ has also been shown to lessen fatigue and reduce stress
Semaglutide, a more potent GLP-1 agonist, has shown greater weight loss efficacy in general populations and appears promising in preliminary post-bariatric reports, though published data remain sparse
Keeping a finger on the pulse of this data will help leaders measure the programs ROI while ensuring employees receive the care and support they need. A benefits landscape in flux This is shaping up to be a pivotal year for the GLP-1 drug class, says Campbell, as a number of macro trends will influence the landscape in which HR and benefits leaders are considering plan design and implementation
In Arlington, where a growing number of individuals embrace plant-based lifestyles or manage busy schedules that disrupt consistent, balanced eating, B12 deficiency can easily go unnoticedyet it might be affecting your energy levels, mood, and metabolism
Removal of GST Tag (Optional) If the GST tag is not required for subsequent experiments, it can be removed by proteolytic cleavage
This was not powered to determine statistical significance, but we did note that those who had improvement had greater weight loss of 6.4 kg and started with marginally higher BMI of 34.2 kg/m 2 before starting the medication, compared to the entire cohort
